2.0
8. März 2015
Aktueller Mitarbeiter, mehr als 3 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good salary plus bonus package Huge company (for some this can be a pro) Promising pipeline, mainly in the Oncology division
Kontras
Huge company where the individual doesn't count Company culture of immediate results, detrimental to long term planning A pletora of processes and systems that do not fit / talk to each other, leading to redundancy, quality issues Shareholders are more important than employees